Table 3.
HPV+ | HPV− | p | |
---|---|---|---|
Age (years) | 45.1 ± 13.6 | 46.7 ± 12.9 | 0.582 |
Duration of immunotherapy (months) | 102.0 ± 68.7 | 93.1 ± 85.7 | 0.495 |
BMI | 25.01 ± 5.31 | 24.18 ± 4.97 | 0.418 |
Habitat | 0.156 | ||
Town > 100 000 | 14 (15.6%) | 29 (32.2%) | |
Town < 100 000 | 7 (7.8%) | 10 (11.1%) | |
Village | 5 (5.6%) | 25 (27.8%) | |
Education | 0.367 | ||
Primary | 3 (3.3%) | 3 (3.3%) | |
Secondary | 5 (5.6%) | 19 (21.1%) | |
Vocational | 6 (6.7%) | 20 (22.2%) | |
Higher | 12 (13.3%) | 22 (24.4%) | |
Age at sexual initiation (years) | 20.08 ± 3.63 | 20.33 ± 4.56 | 0.763 |
Number of lifetime | |||
sexual partners (0–6) | |||
1 | 10 (11.1%) | 41 (45.6%) | 0.026 |
≥2 | 16 (17.8%) | 23 (25.6%) | |
Oral contraception users | 12 (13.3%) | 21 (23.3%) | 0.234 |
Sexual orientation | 0.700 | ||
Heterosexual | 24 (30%) | 55 (68.75%) | |
Homosexual | 0 | 0 | |
Bisexual | 0 | 1 (1.5%) | |
History of STDs | 1 (1.2%) | 1 (1.2%) | 0.500 |
Smoking | 2 (2.3%) | 4 (4.5%) | 0.820 |
HPV—human papillomavirus; HPV+—women positive for high-risk human papillomavirus; HPV−—women negative for high-risk human papillomavirus; BMI—body mass index; STDs—sexually transmitted diseases.